CVS Health Corporation (CVS)

Over the past year, CVS Health's stock price has increased significantly. Key events impacting the stock price include positive analyst sentiment and drug coverage, positive media commentary, growth in the Pharmacy & Consumer Wellness segment, the acquisition of Rite Aid assets, and an ongoing insulin-pricing lawsuit.

Demand for CVS Health Corp.'s products and services exhibits seasonality, particularly within its Pharmacy & Consumer Wellness segment. The first quarter often sees increased revenues due to seasonal trends like high vaccine demand and a longer-than-usual flu season. The fall season brings a surge in shoppers seeking wellness essentials and immunizations. The back-to-school period also sees increased demand, with a notable rise in personal care curbside pickup purchases. The front store business shows steady improvement from an expanding customer base.

CVS Health Corporation is a multinational healthcare company operating as a health solutions provider, primarily in managed healthcare, health insurance, and pharmacy industries. Its core business segments include Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness. The company operates retail pharmacies offering various products and services, provides pharmacy benefit management services, offers health insurance plans, operates walk-in medical clinics, provides specialty pharmacy services, and offers senior pharmacy care.

CVS Health Corp. primarily operates across the United States, maintaining a network of more than 9,100 retail locations. MinuteClinic has over 1,100 locations in 33 states and the District of Columbia, with more than 50% of the U.S. population living within 10 miles of a MinuteClinic. CVS Health also serves medical members in certain countries outside the United States.

CVS Health has consistently maintained a strong brand reputation. Events affecting the company's reputation include a brand refresh with new packaging, the introduction of new product lines, and the acquisition of Rite Aid assets.

Institutional investors hold a substantial portion of CVS Health Corp.'s shares, ranging from approximately 76% to 88% of the company. The top 10 institutional investors collectively own 44% of the company. Retail and individual investors own approximately 11% to 43.97% of the company, while insiders own under 1% of the stock.